Parkside Financial Bank & Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107K | Sell |
476
-22
| -4% | -$5.48K | 0.01% | 658 |
|
|
2025
Q4 | $120K | Buy |
498
+15
| +3% | +$3.84K | 0.01% | 627 |
|
|
2025
Q3 | $132K | Buy |
483
+11
| +2% | +$3K | 0.01% | 570 |
|
|
2025
Q2 | $122K | Buy |
472
+11
| +2% | +$2.62K | 0.01% | 590 |
|
|
2025
Q1 | $103K | Buy |
461
+11
| +2% | +$2.57K | 0.01% | 569 |
|
|
2024
Q4 | $103K | Buy |
450
+10
| +2% | +$2.41K | 0.01% | 557 |
|
|
2024
Q3 | $107K | Buy |
440
+15
| +4% | +$3.35K | 0.02% | 530 |
|
|
2024
Q2 | $81.4K | Buy |
425
+5
| +1% | +$1.01K | 0.01% | 572 |
|
|
2024
Q1 | $83.2K | Buy |
420
+17
| +4% | +$3.12K | 0.01% | 582 |
|
|
2023
Q4 | $69.3K | Buy |
403
+159
| +65% | +$24.4K | 0.01% | 590 |
|
|
2023
Q3 | $36.1K | Buy |
244
+37
| +18% | +$6.69K | 0.01% | 723 |
|
|
2023
Q2 | $45.2K | Buy |
207
+5
| +2% | +$1.11K | 0.01% | 651 |
|
|
2023
Q1 | $44.2K | Buy |
202
+19
| +10% | +$4.12K | 0.01% | 643 |
|
|
2022
Q4 | $38.1K | Buy |
183
+17
| +10% | +$3.73K | 0.01% | 657 |
|
|
2022
Q3 | $36K | Buy |
166
+11
| +7% | +$2.5K | 0.01% | 611 |
|
|
2022
Q2 | $33K | Buy |
155
+17
| +12% | +$3.62K | 0.01% | 659 |
|
|
2022
Q1 | $33K | Buy |
138
+29
| +27% | +$7.01K | 0.01% | 687 |
|
|
2021
Q4 | $28K | Sell |
109
-5
| -4% | -$1.3K | 0.01% | 708 |
|
|
2021
Q3 | $30K | Sell |
114
-1
| -0.9% | -$273 | 0.01% | 656 |
|
|
2021
Q2 | $28K | Buy |
115
+9
| +8% | +$1.89K | 0.01% | 677 |
|
|
2021
Q1 | $21K | Sell |
106
-3
| -3% | -$602 | 0.01% | 757 |
|
|
2020
Q4 | $23K | Buy |
109
+4
| +4% | +$798 | 0.01% | 687 |
|
|
2020
Q3 | $18K | Sell |
105
-14
| -12% | -$2.58K | 0.01% | 674 |
|
|
2020
Q2 | $23K | Buy |
119
+28
| +31% | +$4.58K | 0.01% | 605 |
|
|
2020
Q1 | $13K | Buy |
91
+43
| +90% | +$6.85K | ﹤0.01% | 671 |
|
|
2019
Q4 | $7K | Buy |
48
+9
| +23% | +$1.3K | ﹤0.01% | 873 |
|
|
2019
Q3 | $5K | Hold |
39
| – | – | ﹤0.01% | 947 |
|
|
2019
Q2 | $5K | Buy |
39
+13
| +50% | +$1.44K | ﹤0.01% | 973 |
|
|
2019
Q1 | $3K | Sell |
26
-43
| -62% | -$4.44K | ﹤0.01% | 1094 |
|
|
2018
Q4 | $8K | Buy |
69
+50
| +263% | +$5.36K | ﹤0.01% | 811 |
|
|
2018
Q3 | $2K | Buy |
19
+3
| +19% | +$329 | ﹤0.01% | 1120 |
|
|
2018
Q2 | $2K | Buy |
16
+2
| +14% | +$202 | ﹤0.01% | 1094 |
|
|
2018
Q1 | $1K | Buy |
+14
| New | +$1.32K | ﹤0.01% | 1266 |
|
Other funds holding RMD
VCM
VPM
DAM
Parkside Financial Bank & Trust's RMD Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its ResMed (RMD) stake by 4.4% in Q1 2026, selling an estimated $5.48K and leaving 476 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #658.
Parkside Financial Bank & Trust first reported a position in RMD in Q1 2018 and has held it in 33 quarters since. The position peaked at $132K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Parkside Financial Bank & Trust held 476 shares of ResMed worth $107K as of Q1 2026.
- Parkside Financial Bank & Trust sold 22 ResMed shares in Q1 2026, an estimated $5.48K.
- ResMed made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #658 holding.
- Parkside Financial Bank & Trust first reported a position in ResMed in Q1 2018 and has held it in 33 quarters since.
- Parkside Financial Bank & Trust's ResMed position peaked at $132K in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.